EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy

Bianca-Ștefania Profire iD, Florentina Geanina Lupașcu iD, Alexandru Sava iD, Ioana-Andreea Turin-Moleavin, Dana Bejan iD, Cristian Stătescu iD, Victorița Șorodoc iD, Radu-Andy Sascău, Laurențiu Șorodoc, Mariana Pinteala iD, Lenuța Profire iD

Pharmaceutics · 26.07.2025 · 17 (8) · 969

DOI: 10.3390/pharmaceutics17080969 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutics, online erschienen am 26.07.2025. Verfasst von Bianca-Ștefania Profire und 10 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iași, Romania. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerul Cercetării și Inovării, Ministry of Research, Innovation, and Digitization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: As novel synergistic strategy for heart failure (HF), this study explores the formulation and characterization of liposomal systems co-loaded with SGLT2 inhibitors (dapagliflozin—DAPA and empagliflozin—EMPA) and curcumin (Cur).

Methods

To enhance liposomal membrane stability and achieve sustained, controlled drug release, oleanolic acid (OA) was incorporated into the lipid bilayer, while the liposomal surface was coated with polyvinylpyrrolidone (PVP).

Results

The resulting liposomes exhibited favorable physico-chemical properties (particle size ~170 nm, low PDI, negative zeta potential), high encapsulation efficiencies (up to 97%), and spherical morphology as confirmed by STEM. XRD and DSC analyses indicated successful API incorporation and amorphization within the lipid matrix, while PVP coating provided slight improvements in thermal stability. Trehalose proved to be an effective cryoprotectant, preserving liposome integrity after freeze-drying. In vitro release studies demonstrated sustained and delayed drug release, especially in PVP-coated and OA-containing formulations.

Conclusions

All these findings highlight the promise of PVP-coated, OA-stabilized liposomal formulations co-loaded with SGLT2 inhibitors and Cur as biocompatible, multifunctional platforms for targeted HF therapy.

Schlagwörter

Stichwörter der Autor:innen

SGLT2 inhibitorscurcuminheart failureliposomes

Autor:innen und Institutionen

  • Faculty of Medicine, "Grigore T. Popa" University of Medicine and Pharmacy of Iasi, 16 University Street, 700115 Iași, Romania.
  • Faculty of Pharmacy, "Grigore T. Popa" University of Medicine and Pharmacy of Iași, 16 University Street, 700115 Iași, Romania.
  • "Petru Poni" Institute of Macromolecular Chemistry, 41A Grigore Ghica-Voda Alley, 700487 Iasi, Romania.
  • Institute for Cardiovascular Diseases "Prof. Dr. George I.M. Georgescu", 50 Carol I Boulevard, 700503 Iași, Romania.
  • "Sf. Spiridon" Clinical Emergency Hospital, 1 Independence Boulevard, 700111 Iași, Romania.

ORCID-Profile: Bianca-Ștefania Profire, Florentina Geanina Lupașcu, Alexandru Sava, Dana Bejan, Cristian Stătescu, Victorița Șorodoc, Mariana Pinteala, Lenuța Profire

Förderung

  • Ministerul Cercetării și Inovării
  • Ministry of Research, Innovation, and Digitization

Zitieren

APA

Profire, B. Ș., Lupașcu, F. G., Sava, A., Turin-Moleavin, I. A., Bejan, D., Stătescu, C., Șorodoc, V., Sascău, R. A., Șorodoc, L., Pinteala, M., & Profire, L. (2025). SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics, 17(8), 969. https://doi.org/10.3390/pharmaceutics17080969

Vancouver

Profire BȘ, Lupașcu FG, Sava A, Turin-Moleavin IA, Bejan D, Stătescu C, et al. SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy. Pharmaceutics. 2025;17(8):969. doi:10.3390/pharmaceutics17080969

BibTeX
@article{Profire2025,
  author = {Profire, Bianca-Ștefania and Lupașcu, Florentina Geanina and Sava, Alexandru and Turin-Moleavin, Ioana-Andreea and Bejan, Dana and Stătescu, Cristian and Șorodoc, Victorița and Sascău, Radu-Andy and Șorodoc, Laurențiu and Pinteala, Mariana and Profire, Lenuța},
  title = {SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy},
  journal = {Pharmaceutics},
  year = {2025},
  volume = {17},
  number = {8},
  pages = {969},
  doi = {10.3390/pharmaceutics17080969}
}
Kostenlos starten →